Analyst Consensus ?
ConsensusBuy22 ratings
Bullish1881.8%
Neutral418.2%
Bearish00.0%
FN2 Earnings Intelligence
Ares Management Corporation (ARES) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 8, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Oppenheimer | Outperform | Outperform | Maintain | Aug 27, 2026 |
| TD Cowen | Buy | Buy | Maintain | Aug 3, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 3, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Aug 3, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Aug 3, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Jul 9, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 9, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Apr 21, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 7, 2026 |
| Raymond James | Strong Buy | Market Perform | Upgrade | Feb 9, 2026 |
| Deutsche Bank | Buy | Hold | Upgrade | Feb 9, 2026 |
| UBS | Neutral | Neutral | Maintain | Jan 13, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Nov 4, 2025 |
| B of A Securities | Buy | Buy | Maintain | Oct 3, 2025 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Aug 6, 2025 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 11, 2025 |
| Jefferies | Hold | Hold | Maintain | May 9, 2024 |
| Piper Sandler | Overweight | Overweight | Maintain | Feb 13, 2023 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Nov 25, 2020 |
| Keefe Bruyette & Woods | Outperform | Outperform | Maintain | Nov 25, 2020 |
| Credit Suisse | Outperform | Neutral | Upgrade | Nov 25, 2020 |
| Bank of America | Buy | Neutral | Upgrade | Nov 25, 2020 |
Upside is calculated against the persisted current price $115.26. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Daniel Welden | $136 | $116.57 | +18.0% | Oct 1, 2026 |
| Piper Sandler | Crispin Love | $150 | $121.48 | +30.1% | Sep 24, 2026 |
| RBC Capital | Bart Dziarski | $168 | $134.39 | +45.8% | Aug 3, 2026 |
| Deutsche Bank | Analyst unavailable | $144 | $135.01 | +24.9% | Aug 3, 2026 |
| Oppenheimer | Analyst unavailable | $151 | $133.2 | +31.0% | Aug 3, 2026 |
| BMO Capital | Brennan Hawken | $134 | $128.09 | +16.3% | Aug 3, 2026 |
| Morgan Stanley | Analyst unavailable | $160 | $121.14 | +38.8% | Jul 21, 2026 |
| BMO Capital | Analyst unavailable | $128 | $122.06 | +11.1% | Jul 13, 2026 |
| Barclays | Analyst unavailable | $139 | $120.29 | +20.6% | Jul 9, 2026 |
| Barclays | Analyst unavailable | $140 | $119.06 | +21.5% | May 4, 2026 |
| Morgan Stanley | Analyst unavailable | $163 | $122.32 | +41.4% | Apr 21, 2026 |
| RBC Capital | Bart Dziarski | $173 | $115.94 | +50.1% | Feb 24, 2026 |
| UBS | Analyst unavailable | $148 | $128.16 | +28.4% | Feb 20, 2026 |
| RBC Capital | Analyst unavailable | $180 | $135.12 | +56.2% | Feb 9, 2026 |
| Oppenheimer | Analyst unavailable | $215 | $128.94 | +86.5% | Feb 6, 2026 |
| Goldman Sachs | Analyst unavailable | $165 | $128.7 | +43.2% | Feb 6, 2026 |
| Barclays | Analyst unavailable | $190 | $121.87 | +64.8% | Feb 6, 2026 |
| Deutsche Bank | Brian Bedell | $155 | $121.87 | +34.5% | Feb 6, 2026 |
| Morgan Stanley | Analyst unavailable | $178 | $149.69 | +54.4% | Jan 27, 2026 |
| Oppenheimer | Analyst unavailable | $224 | $167.03 | +94.3% | Jan 20, 2026 |
| UBS | Analyst unavailable | $198 | $169.5 | +71.8% | Jan 13, 2026 |
| Barclays | Analyst unavailable | $222 | $175.75 | +92.6% | Jan 9, 2026 |
| Wolfe Research | Analyst unavailable | $210 | $172.84 | +82.2% | Jan 7, 2026 |
| Barclays | Analyst unavailable | $218 | $176.82 | +89.1% | Dec 12, 2025 |
| UBS | Michael Brown | $201 | $178.3 | +74.4% | Dec 11, 2025 |
| Oppenheimer | Chris Kotowski | $190 | $153.75 | +64.8% | Nov 4, 2025 |
| Morgan Stanley | Analyst unavailable | $175 | $149.21 | +51.8% | Oct 21, 2025 |
| Oppenheimer | Analyst unavailable | $180 | $143.63 | +56.2% | Oct 14, 2025 |
| Barclays | Analyst unavailable | $187 | $148.64 | +62.2% | Oct 8, 2025 |
| JMP Securities | Brian McKenna | $195 | $180.34 | +69.2% | Jul 14, 2025 |
| Wolfe Research | Steven Chubak | $193 | $159.63 | +67.4% | May 6, 2025 |
| Barclays | Benjamin Budish | $182 | $160.96 | +57.9% | May 6, 2025 |
| Wolfe Research | Steven Chubak | $218 | $180.87 | +89.1% | Jan 3, 2025 |
| RBC Capital | Kenneth Lee | $205 | $176.11 | +77.9% | Dec 10, 2024 |
| RBC Capital | Kenneth Lee | $170 | $157.81 | +47.5% | Oct 11, 2024 |
| Morgan Stanley | Michael Cyprys | $162 | $156.95 | +40.6% | Oct 10, 2024 |
| Barclays | Benjamin Budish | $174 | $160.39 | +51.0% | Oct 7, 2024 |
| CFRA | Kenneth Leon | $170 | $156.38 | +47.5% | Sep 23, 2024 |
| Wells Fargo | Michael Brown | $156 | $141.46 | +35.3% | Sep 11, 2024 |
| Redburn Partners | Nicholas Watts | $140 | $146.96 | +21.5% | Aug 27, 2024 |
| Barclays | Benjamin Budish | $155 | $139.26 | +34.5% | Aug 5, 2024 |
| CFRA | Kenneth Leon | $155 | $139.26 | +34.5% | Aug 2, 2024 |
| Barclays | Benjamin Budish | $151 | $134.78 | +31.0% | Jul 10, 2024 |
| Deutsche Bank | Brian Bedell | $132 | $137.49 | +14.5% | Jun 13, 2024 |
| Deutsche Bank | Brian Bedell | $176 | $146.7 | +52.7% | May 28, 2024 |
| UBS | Brent Dilts | $160 | $146.31 | +38.8% | May 22, 2024 |
| RBC Capital | Kenneth Lee | $150 | $136.17 | +30.1% | May 7, 2024 |
| Barclays | Benjamin Budish | $150 | $134.64 | +30.1% | May 3, 2024 |
| Barclays | Analyst unavailable | $87 | $75.1 | -24.5% | Jan 12, 2023 |
| Barclays | Analyst unavailable | $82 | $68.14 | -28.9% | Dec 19, 2022 |
| UBS | Analyst unavailable | $95 | $79.53 | -17.6% | Nov 15, 2022 |
| BMO Capital | Analyst unavailable | $87 | $68.79 | -24.5% | Apr 29, 2022 |
| Morgan Stanley | Analyst unavailable | $90 | $81.94 | -21.9% | Apr 20, 2022 |
| Wells Fargo | Analyst unavailable | $92 | $79.71 | -20.2% | Apr 19, 2022 |
| Barclays | Jeremy Campbell | $62 | $53.55 | -46.2% | Apr 12, 2021 |
Track every rating change on ARES the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.